PMC:7755033 / 15295-15693 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7755033","sourcedb":"PMC","sourceid":"7755033","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7755033","text":"o docking, energy minimization of ligands was carried out using Merck Molecular Force Field (MMFF94) in order to achieve a better relaxation in the arrangement of atoms.\nThe PubChem IDs of the reference drugs and selected ligands were as follows: arbidol (CID-131411), losartan (CID-3961), procainamide (CID-4913), cinacalcet (CID-156419), oberadilol (CID-3047798), poziotinib (CID-25127713), hydro","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"327","span":{"begin":327,"end":337},"obj":"Disease"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"attributes":[{"subj":"327","pred":"source","obj":"LitCovid-PubTator"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#93bcec","default":true}]}]}}